Current Trends in Management of Fetal Growth Restriction

Abstract

Fetal growth restriction (FGR) or intrauterine growth restriction (IUGR) are the terms used for a fetus which has not attained its full growth potential. FGR fetus is associated with high perinatal and neonatal morbidity and mortality, besides long term neurological handicap because of in utero hypoxia. Three decades of research has indicated that almost all treatment strategies are ineffective in treating FGR. Panorama of management includes identifying women at risk, correct dating, distinguishing between a constitutionally small and a true FGR, monitoring for fetal hypoxia, growth, and a timely intervention to avoid death or damage.

Current trends in the treatment of chronic placental insufficiency

“…Одна из важнейших задач практического здравоохранения и медицинской науки -снижение перинатальной заболеваемости и смертности, причиной которых часто становится плацентарная недостаточность. Оптимизация профилактики и лечения плацентарной недостаточности и синдрома задержки роста плода является приоритетным вопросом современного акушерства [35][36][37][38].…”

Untitled

“…In 2014, we published articles of practical utility on ''growth restriction [28] and Rh iso-immunization [29]. The commonest single gene disorder in India is beta thalassemia, and the carrier frequency among various ethnic groups varies from 3 to 15 %.…”

Advancing Horizons in Fetal Medicine

“…Genetic studies are an important component of fetal autopsies, not only in cases of congenital malformations, but also in unexplained intrauterine death and sudden unexpected death in infancy [19]. We also published articles on management of Rh isoimmunization [20], growth restriction [21] and prenatal diagnosis of lysosomal storage disorders [22].…”